|
Stereotactic Radiation Therapy in Treating Patients With Brain Metastases Clinical Trials Resources presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, visits or professional assistance with a real medical. We aren't doctors. Always consult your mD about Stereotactic Radiation Therapy in Treating Patients With Brain Metastases conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Stereotactic Radiation Therapy in Treating Patients With Brain Metastases Clinical research trials and Stereotactic Radiation Therapy in Treating Patients With Brain Metastases health trials occur in a lot of of places throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / projects is to resolve certain human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to detect remedies for all varieties of circumstances, such as Stereotactic Radiation Therapy in Treating Patients With Brain Metastases. Stereotactic Radiation Therapy in Treating Patients With Brain Metastases Clinical Trials and other clinical trials allow volunteers to obtain health treatment choices before they are available to the general public. Most times the human subjects recieve professional assistance for free of charge, and every now and again they are paid for their time. Sometimes there is a cost for a Stereotactic Radiation Therapy in Treating Patients With Brain Metastases clinical trial. Human subjects frequently get the finest healthcare available for their Stereotactic Radiation Therapy in Treating Patients With Brain Metastases condition. Risks are a reality, however, and may include extra or frequent physician visits, medical dangers (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Stereotactic Radiation Therapy in Treating Patients With Brain Metastases  Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
For Condition: brain metastases
Status: No longer recruiting
Sponsor(s): National Cancer Institute (NCI) , Ireland Cancer Center
Synopsis: RATIONALE: Stereotactic radiation therapy may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: Phase II trial to study the effectiveness of stereotactic radiation therapy in treating patients who have brain metastases.
Details: OBJECTIVES: I. Determine the efficacy of stereotactic radiosurgery without whole brain radiotherapy in elderly patients or patients with poor performance status who have brain metastases. II. Determine the neurologic function in these patients after receiving this treatment regimen. III. Determine the quality of life in these patients with this treatment regimen. PROTOCOL OUTLINE: Patients undergo stereotactic head frame placement, followed by stereotactic radiosurgery using Gamma Knife, on day 1. Quality of life is assessed one week prior to and one week after treatment, and then at 2, 4, 6, 8, 10, and 12 months. Patients are followed at one week, at 2, 4, 6, 8, 10, and 12 months, every 4 months for one year, and then every 6 months for 3 years. PROJECTED ACCRUAL: Approximately 52 patients will be accrued for this study within 2 years.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders:
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Patients with 1-4 sites of brain metastases; Confirmed by MRI with gadolinium texaphyrin scan within two weeks of study; If solitary metastases, diameter must be 40 mm or less; If multiple metastases, one site may be greater than 30 mm, while all others must be less than 30 mm; No metastases in the brainstem or within 5 mm of optic nerves or chiasm - Prior surgical resection of metastases allowed if radiographically visible residual disease - No prior cranial radiotherapy - Patients must be over 65 years of age OR Over 18 years of age with Karnofsky performance status 40-60% - All primary histologies allowed except the following: Lymphomas; Leukemia; Multiple myeloma; Small cell lung cancer; Germ cell tumors - Extracranial disease allowed --Prior/Concurrent Therapy-- - Biologic therapy: Not specified - Chemotherapy: Prior chemotherapy allowed - Endocrine therapy: Not specified - Radiotherapy: See Disease Characteristics; Prior or concurrent radiotherapy to noncranial sites allowed - Surgery: See Disease Characteristics --Patient Characteristics-- - Age: See Disease Characteristics - Performance status: See Disease Characteristics - Life expectancy: Not specified - Hematopoietic: Hemoglobin greater than 8 g/dL; Absolute neutrophil count greater than 1,000/mm3; Platelet count greater than 50,000/mm3 - Hepatic: Not specified - Renal: Not specified
Total Enrollment:
Location and Contact Information:
Overall Study Official:
DonaldShina, Study Chair, Ireland Cancer Center
Ireland Cancer Center
Cleveland, Ohio, 44106-5065
United States
Additional Information:
Study ID Numbers: CDR0000068193; CWRU-3399,NCI-G00-1853
Study Start Date: January 2000
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006259
Other Brain Metastases Studies:
1. Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
2. Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
3. Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
4. Radiation Therapy in Preventing CNS Metastases in Patients With Non-Small Cell Lung Cancer
5. Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
Related Studies:
Other brain metastases Clinical Trials
Other Ohio Clinical Trials
Other Cleveland Clinical Trials
Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
|
|
|
|
|
|
|
|
